"How is it that the person in charge has no clue a
Post# of 153778
(Total Views: 639)
Posted On: 05/13/2020 12:10:28 AM
"How is it that the person in charge has no clue about Leronlimab?"
He definitely has a clue, but he is thinking about a whole lot more things (like epidemiology and vaccines) and is a whole lot more interested in what the proven BPs like Gilead, Moderna, Roche, etc. have to say than a pipsqueak startup who's working on a strange new theory. He may not know very much at all about leronlimab.
On the other hand, he most likely knows WAY more valuable information than 'most any of us. A few well-placed sentences would be worth a heck of a lot more than all the articles and papers we can read and all the webinars and conference calls we can listen to.
"he is aware and is willfully not saying anything, not even a hint. Why?"
I think he did give a hint today. He mentioned mab for HIV looking promising. There are lots of mab's being discussed, but any HIV mab's besides leronlimab?
"only two answers are possible. One--because he doesn't want to mention any names before a drug has proved itself in the trial."
Certainly. It would be bordering on unprofessional for him to name leronlimab prematurely (like DJT naming HQC---mistake).
"Two--Fauci is a lead agent of the biotech-medical research complex--similar to the military-industrial complex..." surely that's true and will defend their interests. But he's not avoiding the L word to appease them. He's avoiding it because he's the embodiment of the system. He can scarcely conceive of lending an ear to the likes of Cytodyn before it has proved itself worthy. When it has, he will welcome us to the crowd.
He definitely has a clue, but he is thinking about a whole lot more things (like epidemiology and vaccines) and is a whole lot more interested in what the proven BPs like Gilead, Moderna, Roche, etc. have to say than a pipsqueak startup who's working on a strange new theory. He may not know very much at all about leronlimab.
On the other hand, he most likely knows WAY more valuable information than 'most any of us. A few well-placed sentences would be worth a heck of a lot more than all the articles and papers we can read and all the webinars and conference calls we can listen to.
"he is aware and is willfully not saying anything, not even a hint. Why?"
I think he did give a hint today. He mentioned mab for HIV looking promising. There are lots of mab's being discussed, but any HIV mab's besides leronlimab?
"only two answers are possible. One--because he doesn't want to mention any names before a drug has proved itself in the trial."
Certainly. It would be bordering on unprofessional for him to name leronlimab prematurely (like DJT naming HQC---mistake).
"Two--Fauci is a lead agent of the biotech-medical research complex--similar to the military-industrial complex..." surely that's true and will defend their interests. But he's not avoiding the L word to appease them. He's avoiding it because he's the embodiment of the system. He can scarcely conceive of lending an ear to the likes of Cytodyn before it has proved itself worthy. When it has, he will welcome us to the crowd.
(7)
(0)